WA
ELV icon

Winfield Associates’s Elevance Health ELV Stock Holding History

Winfield Associates’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,650
Closed -$332K – 748
2016
Q3 		$332K Hold
2,650
– – 0.21% 89
2016
Q2 		$348K Hold
2,650
– – 0.23% 85
2016
Q1 		$368K Hold
2,650
– – 0.25% 80
2015
Q4 		$370K Hold
2,650
– – 0.25% 76
2015
Q3 		$371K Buy
2,650
+600
+29% +$90.2K 0.28% 75
2015
Q2 		$336K Buy
2,050
+450
+28% +$71.9K 0.23% 87
2015
Q1 		$247K Buy
+1,600
New +$228K 0.17% 97

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Winfield Associates's ELV Position: Q4 2016 in Review

Winfield Associates sold out of Elevance Health (ELV) in Q4 2016, closing a stake of 2,650 shares — an estimated $332K sold.

Winfield Associates first reported a position in ELV in Q1 2015 and held it in 7 quarters. The position peaked at $371K in Q3 2015. 784 funds tracked by Wall St. Rank hold ELV as of Q4 2016.

  • Winfield Associates reported no remaining Elevance Health position as of Q4 2016 after selling out during the quarter.
  • Winfield Associates sold 2,650 Elevance Health shares in Q4 2016, an estimated $332K.
  • Winfield Associates first reported a position in Elevance Health in Q1 2015 and held it in 7 quarters.
  • Winfield Associates's Elevance Health position peaked at $371K in Q3 2015.
  • 784 funds tracked by Wall St. Rank held Elevance Health as of Q4 2016.

Based on Winfield Associates's 13F filing for Q4 2016, filed 20 Jan 2017.